You are here:

Atorvastatin (Lipitor®)

Advice

Following an abbreviated submission

Atorvastatin calcium (Lipitor) is accepted for restricted use in the NHS in Scotland as an adjunct to diet for the reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in children aged 10 years and older with primary hypercholesterolaemia, heterozygous familial hypercholesterolaemia or combined (mixed) hyperlipidaemia when response to diet and other non-pharmacological measures is inadequate.

It is restricted to initiation by paediatricians or physicians specialising in the management of lipid disorders.

Drug Details

Drug Name: Atorvastatin (Lipitor®)
SMC Drug ID: 202/05
Manufacturer: Pfizer Ltd
Indication: Reduction of elevated total cholesterol, LDL-cholesterol, apolipoprotein B and triglycerides in children aged 10 years and older with primary hypercholesterolaemia, heterozygous familial hypercholeste
BNF Category:
Sub Category: 2.12 Lipid-regulating drugs
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 10 October 2005

Back